HeartBEATS from Lifelong Learning™ American Heart Association
-
- Health & Fitness
-
HeartBEATS from Lifelong Learning™ is a series curated by the AHA. Tune in as experts explore highlights on the most up-to-date information to inform your clinical practice.
-
- video
Selecting the Right Anticoagulation for Your Patient
In this episode, a panel of experts discuss existing VTE treatment options, algorithms, corresponding safety and efficacy profiles along with safety and efficacy data, and protocols to address treatment pathways.
Claim CE and MOC Credit at https://bit.ly/VTEIII -
- video
SARS-CoV-2 and the Omicron Variant: The Viral Lifecycle and Therapeutic Implications for Primary Care
COVID-19 care is now mostly provided outside of hospital settings. Early diagnosis and therapeutic intervention for those who are at increased risk of progression to severe COVID-19 may improve outcomes. Dr. Jeff Hsu talks with Dr. Mary Brennan about the symptoms associated with the different stages of SARS-CoV-2 and choosing the appropriate outpatient therapeutic treatment.
CE and ABIM MOC credits available: https://bit.ly/3PeZRIy
-
- video
Practical Pointers to Optimize the Use of GLP-1 RAs
Conversation about the approved GLP-1 RAs to manage type 2 diabetes mellitus (T2DM). Forms of administration, contextualizing the many benefits and the risks, and indications will be discussed.
Claim CE Credit at https://bit.ly/49Ultlu -
- video
Obesity and GLP-1 RAs
Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity.
Claim CE Credit at https://bit.ly/3OkYJm9 -
- video
Chronic Kidney Disease and GLP-1 RAs
Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP-1 RA use in this population.
Claim CE and MOC Credit at https://bit.ly/4aNc3t8 -
- video
Cardiovascular Benefits of GLP-1 RAs
Conversation around specific cardiovascular risks, while distinguishing between glycemic control and cardiovascular risk reduction. We will also highlight the benefits of treatment with GLP-1 RA in patients with diabetes.
Claim CE and MOC Credit at https://bit.ly/3SbyErW
Customer Reviews
Very informative educational offering
Thank you for informative series. Speakers are excellent.